Company
Exactech
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
49
510(k), De Novo and PMA
Device trials
7
As lead sponsor, any status
Adverse event reports
1,832
Received Nov 1, 2025 to Nov 19, 2026
Recall records
221
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Exactech, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Exactech.
Latest FDA decisions
The 8 newest of 49 since 2015.
K260583 · Decided Apr 14, 2026 · 53 days after receipt
Device type: Shoulder Prosthesis, Reverse Configuration (PHX) · Orthopedic Surgery
K250713 · Decided Dec 1, 2025 · 266 days after receipt
Device type: Prosthesis, Shoulder, Non-Constrained, Metal/Polymer Cemented (KWT) · Orthopedic Surgery
K243448 · Decided Aug 1, 2025 · 267 days after receipt
Device type: Shoulder Prosthesis, Reverse Configuration (PHX) · Orthopedic Surgery
46 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Exactech Knee Systems Post Market Clinical Follow-upEnrolling by invitation
NCT07107581 · 1,879 participants (planned) · Start Dec 1, 2023 · Primary completion Dec 2035
Device: Prospective / Subjects Knee Arthroplasty; Retrospective to Prospective and 1 more · For: Knee Arthroplasty, Total; Partial Knee Replacement
Sites: DeLand, Florida
- Evaluation of Navigation-Assisted TKA Using Mechanical vs. Restricted Kinematic AlignmentPivotal-lookingRecruiting
NCT05516381 · 148 participants (planned) · Start May 15, 2023 · Primary completion Dec 2026
Device: Optetrak Logic CR Knee System · For: Knee Arthroplasty, Total
Sites: Barcelona, Spain
- A Post-Market Domestic (US) and International Data Collection to Assess the Truliant Knee SystemRecruiting
NCT05653102 · 1,000 participants (planned) · Start Jan 23, 2019 · Primary completion Jan 31, 2035
Device: Truliant Total Knee System · For: Knee Arthroplasty, Total
Sites: Aurora, Colorado; DeLand, Florida; Las Vegas, Nevada · 5 sites in all
4 more trials with a free account
Reports received
1,832
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
34
1.9% of reports
Injury reports
1,797
98% of reports
Death reports
1
0.1% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 5 | 186 | 0 | 0 |
| Jan 24 | 4 | 140 | 0 | 0 |
| Feb 24 | 4 | 221 | 1 | 0 |
| Mar 24 | 5 | 327 | 0 | 0 |
| Apr 24 | 5 | 325 | 0 | 0 |
| May 24 | 6 | 636 | 2 | 1 |
| Jun 24 | 4 | 544 | 0 | 0 |
| Jul 24 | 4 | 405 | 0 | 2 |
| Aug 24 | 5 | 579 | 1 | 0 |
| Sep 24 | 4 | 551 | 0 | 0 |
| Oct 24 | 2 | 443 | 0 | 0 |
| Nov 24 | 2 | 339 | 0 | 0 |
| Dec 24 | 2 | 565 | 0 | 0 |
| Jan 25 | 1 | 605 | 0 | 0 |
| Feb 25 | 29 | 699 | 7 | 0 |
| Mar 25 | 12 | 346 | 0 | 0 |
| Apr 25 | 0 | 256 | 0 | 0 |
| May 25 | 3 | 249 | 0 | 0 |
| Jun 25 | 2 | 189 | 0 | 0 |
| Jul 25 | 3 | 254 | 0 | 0 |
| Aug 25 | 1 | 209 | 0 | 0 |
| Sep 25 | 1 | 159 | 0 | 0 |
| Oct 25 | 1 | 231 | 0 | 0 |
| Nov 25 | 1 | 204 | 0 | 0 |
| Dec 25 | 7 | 191 | 0 | 0 |
| Jan 26 | 3 | 92 | 0 | 0 |
| Feb 26 | 2 | 110 | 0 | 0 |
| Mar 26 | 1 | 156 | 0 | 0 |
| Apr 26 | 4 | 160 | 0 | 0 |
| May 26 | 3 | 151 | 0 | 0 |
| Jun 26 | 4 | 141 | 0 | 0 |
| Jul 26 | 3 | 143 | 0 | 0 |
| Aug 26 | 4 | 145 | 0 | 0 |
| Sep 26 | 2 | 141 | 0 | 0 |
| Oct 26 | 0 | 163 | 1 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
7 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
- EQUINOXE86
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Brand Name: Equinoxe Ergo Product Name: Ergo Modular Impactor Handle Model/Catalog Number: 321-09-05Open, Classified
Z-1509-2026 · Started Feb 3, 2026 · Posted by FDA Mar 9, 2026
Reason given: Impactor handle may be missing cross-pin
Cause as FDA categorized it: Under Investigation by firm · Device type: Impactor (HWA)
- Brand Name: Equinoxe Product Name: Equinoxe Core Instrument Kit Model/Catalog Number: KIT-311XOpen, Classified
Z-1510-2026 · Started Feb 3, 2026 · Posted by FDA Mar 9, 2026
Reason given: Impactor handle may be missing cross-pin
Cause as FDA categorized it: Under Investigation by firm · Device type: Impactor (HWA)
Z-0535-2026 · Started Sep 5, 2025 · Posted by FDA Nov 17, 2025
Reason given: Due to products that have not completed design updates and performance testing being released/distributed. Products may not conform to design and performance criteria.
Cause as FDA categorized it: Release of Material/Component prior to receiving test results · Device type: Shoulder Prosthesis, Reverse Configuration (PHX)
218 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.